Boston Scientific(US:BSX) Jing Ji Guan Cha Wang·2025-12-19 14:55Core Insights - Boston Scientific showcased 13 innovative minimally invasive products at the Import Expo, focusing on common diseases such as atrial fibrillation, stroke prevention, heart failure, carotid artery stenosis, obesity, benign prostatic hyperplasia, tumors, and Parkinson's disease [1][2] - The FARAWAVE NAV catheter, recently approved, was highlighted as a key product, along with other innovative solutions tailored to the needs of elderly patients in China [2][3] Group 1: Innovative Products - The company introduced several breakthrough therapies, including the SENTINEL embolic protection device for TAVR procedures, the ENROUTE device for carotid artery reconstruction, and the TheraSphere Y90 glass microsphere system for primary liver cancer treatment [3] - Additionally, Boston Scientific presented two weight management technologies, the Orbera365 gastric balloon system and the OverStitch endoscopic suturing device, addressing various obesity treatment needs [3] Group 2: Health Education and Community Engagement - Boston Scientific has invested in health promotion and community engagement, enhancing public health literacy and supporting medical talent development through various initiatives [4] - The company showcased three major public welfare segments at the expo, including a Zhihu science popularization area, patient story documentaries, and an exhibition of public welfare project outcomes [4] Group 3: Future Goals - Leveraging the Import Expo platform, Boston Scientific aims to amplify the outreach of advanced health concepts to a broader audience, contributing to the goal of a healthier China [5]